Artigo de periodico

PD-1/PD-L1 inhibition enhances chemotherapy induced neuropathic pain by suppressing neuroimmune antinociceptive signaling (2022)

• Authors:
  • Wanderley, Carlos Wagner de Souza
  • Maganin, Alexandre Gomes de Macedo
  • Mendes, Atlante Silva
  • Silva, Conceição Elidianne Aníbal
  • Quadros, Andreza Urba de
  • Luiz, João Paulo Mesquita
  • Silva, Camila Meirelles de Souza
  • Silva, Nicole Rodrigues
  • Oliveira, Francisco F
  • Gomes, Francisco Isaac Fernandes
  • Restrepo, Jeffersson Leandro Jimenez
  • Hernandez, Cesar Augusto Speck
  • Turaça, Fernanda
  • Gabriel, Victor Lucena da
  • Pigatto, Glauce Regina
  • Nakaya, Helder Takashi Imoto
  • Mota, Jose Mauricio
  • Sousa, Romualdo Barroso
  • Alves Filho, José Carlos Farias
  • Cunha, Thiago Mattar
  • Cunha, Fernando Queiroz
• USP affiliated authors: NAKAYA, HELDER TAKASHI IMOTO - FCF ; ALVES FILHO, JOSÉ CARLOS FARIAS - FMRP ; CUNHA, THIAGO MATTAR - FMRP ; WANDERLEY, CARLOS WAGNER DE SOUZA - FMRP ; MAGANIN, ALEXANDRE GOMES DE MACEDO - FMRP ; MENDES, ATLANTE SILVA - FMRP ; SILVA, CONCEIÇÃO ELIDIANNE ANIBAL - FMRP ; QUADROS, ANDREZA URBA DE - FMRP ; LUIZ, JOÃO PAULO MESQUITA - FMRP ; SILVA, CAMILA MEIRELLES DE SOUZA - FMRP ; GOMES, FRANCISCO ISAAC FERNANDES - FMRP ; RESTREPO, JEFFERSSON LEANDRO JIMENEZ - FCF ; HERNANDEZ, CESAR AUGUSTO SPECK - FMRP ; SILVA, GABRIEL VICTOR LUCENA DA - FMRP ; PIGATTO, GLAUCE REGINA - FMRP
• Unidades: FCF; FMRP
• DOI: 10.1158/2326-6066.CIR-22-0003
• Subjects: CITOTOXICIDADE IMUNOLÓGICA; IMUNOTERAPIA; MACRÓFAGOS; FARMACOTERAPIA
• Language: Inglês
• Imprenta:
  • Publisher place: Philadelphia
  • Date published: 2022
• Source:
  • Título: Cancer Immunology Research
  • ISSN: 2326-6066
  • Volume/Número/Paginação/Ano: v. 10, n. 11, p. 1299–1308, 2022


Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).

Status:

Artigo possui acesso gratuito no site do editor (Bronze Open Access)

Versão do Documento:

Versão publicada (Published version)

Acessar versão aberta:

• PDF de acesso aberto

Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.

---

Download do texto completo

Tipo	Nome	Link
	003097733.pdf

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  WANDERLEY, Carlos Wagner de Souza et al. PD-1/PD-L1 inhibition enhances chemotherapy induced neuropathic pain by suppressing neuroimmune antinociceptive signaling. Cancer Immunology Research, v. 10, n. 11, p. 1299–1308, 2022Tradução . . Disponível em: https://doi.org/10.1158/2326-6066.CIR-22-0003. Acesso em: 30 mar. 2026.

• APA

  Wanderley, C. W. de S., Maganin, A. G. de M., Mendes, A. S., Silva, C. E. A., Quadros, A. U. de, Luiz, J. P. M., et al. (2022). PD-1/PD-L1 inhibition enhances chemotherapy induced neuropathic pain by suppressing neuroimmune antinociceptive signaling. Cancer Immunology Research, 10( 11), 1299–1308. doi:10.1158/2326-6066.CIR-22-0003

• NLM

  Wanderley CW de S, Maganin AG de M, Mendes AS, Silva CEA, Quadros AU de, Luiz JPM, Silva CM de S, Silva NR, Oliveira FF, Gomes FIF, Restrepo JLJ, Hernandez CAS, Turaça F, Gabriel VL da, Pigatto GR, Nakaya HTI, Mota JM, Sousa RB, Alves Filho JCF, Cunha TM, Cunha FQ. PD-1/PD-L1 inhibition enhances chemotherapy induced neuropathic pain by suppressing neuroimmune antinociceptive signaling [Internet]. Cancer Immunology Research. 2022 ; 10( 11): 1299–1308.[citado 2026 mar. 30 ] Available from: https://doi.org/10.1158/2326-6066.CIR-22-0003

• Vancouver

  Wanderley CW de S, Maganin AG de M, Mendes AS, Silva CEA, Quadros AU de, Luiz JPM, Silva CM de S, Silva NR, Oliveira FF, Gomes FIF, Restrepo JLJ, Hernandez CAS, Turaça F, Gabriel VL da, Pigatto GR, Nakaya HTI, Mota JM, Sousa RB, Alves Filho JCF, Cunha TM, Cunha FQ. PD-1/PD-L1 inhibition enhances chemotherapy induced neuropathic pain by suppressing neuroimmune antinociceptive signaling [Internet]. Cancer Immunology Research. 2022 ; 10( 11): 1299–1308.[citado 2026 mar. 30 ] Available from: https://doi.org/10.1158/2326-6066.CIR-22-0003

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• Nitric oxide favours tumour-promoting inflammation through mitochondria-dependent and -independent actions on macrophages
• Skin-resident dendritic cells mediate postoperative pain via CCR4 on sensory neurons
• Anthrax toxins regulate pain signaling and can deliver molecular cargoes into ANTXR2+ DRG sensory neurons
• Paclitaxel binds and activates C5aR1: a new potential therapeutic target for the prevention of chemotherapy-induced peripheral neuropathy and hypersensitivity reactions
• Regulatory T cells counteract neuropathic pain through inhibition of the Th1 response at the site of peripheral nerve injury
• The Cannabidiol analog PECS-101 prevents chemotherapy-induced neuropathic pain via PPARγ receptors
• Platelets fuel the inflammasome activation of innate immune cells
• Neuron-associated macrophage proliferation in the sensory ganglia is associated with peripheral nerve injury-induced neuropathic pain involving CX3CR1 signaling
• Meningeal dendritic cells drive neuropathic pain through elevation of the kynurenine metabolic pathway in mice
• Inhibition of Tryptophan catabolism is associated with neuroprotection during Zika virus infection